Skip to content

Patient voice — fibromyalgia

This directory is the patient-experience layer of the fibromyalgia (FM) knowledge base: what living with fibromyalgia is actually like, as reported by patients themselves — through patient organizations, published qualitative research, news features, and video testimony. It exists because FM is the paradigm case of a condition where the patient experience is part of the scientific problem: the same illness that trials measure with pain scores is experienced by patients primarily as a battle for legitimacy — being disbelieved by clinicians, family, and employers before, during, and after diagnosis (Åsbring 2002, PMID 11837367; Bontempo 2025, PMID 40310228). Physicians themselves rank fibromyalgia at the very bottom of the disease-prestige hierarchy — dead last of 38 diseases in three successive Norwegian surveys spanning 25 years (Album 2017, PMID 28319909). No account of FM research priorities is complete without this layer.

Files in this layer

File Contents
organizations.md Directory of FM patient organizations and campaigns worldwide — what each offers patients and how each participates in research. Every entry in the main tables was verified during the writing session (see Methodology); unverifiable organizations are quarantined, not silently included. Includes the May 12 awareness-day genealogy.
themes.md Thematic synthesis of patient-reported experience. Every theme is supported by ≥2 independent sources (published qualitative studies with PMIDs, fetched organization pages, news features, video listings).
sources.md Annotated source list: (a) organization pages fetched, (b) news/feature articles fetched, (c) video content identified via search, (d) published qualitative and patient-experience research with PMIDs. Includes an explicit coverage limits note.

The synthesis of this layer into the wiki lives at ../../wiki/patient-experience-and-advocacy.md.

Methodology (how sources were found — session of 2026-08-28)

  1. Published research (PubMed, live queries). Searches combining fibromyalgia with: qualitative, lived experience, illness experience, patient experience, stigma, legitimacy, delegitimation, contested illness, diagnosis experience/journey, attitudes × physicians/GPs/nurses, pacing / boom and bust / activity patterns, work / sick leave / disability pension, social media / online community / YouTube / TikTok, OMERACT / patient perspective / patient priorities, plus author-tracking of known groups (Åsbring & Närvänen; Malterud/Undeland/Werner; Mengshoel; Arnold/Mease/Choy OMERACT work; Album disease-prestige surveys; Bennett/NFA internet survey). Every PMID cited anywhere in this layer was returned by a PubMed tool call in the writing session. FM's qualitative literature is unusually deep — two decades of metasyntheses exist (Sim 2008, PMID 18423826; Mengshoel 2017, PMID 28762775; Climent-Sanz 2023, PMID 37965900; Yung 2025, PMID 40093347) — so this layer privileges syntheses and load-bearing primary studies over exhaustive listing.
  2. Organizations. Started from a seed list (National Fibromyalgia Association, Support Fibromyalgia Network, Fibromyalgia Care Society of America, Fibromyalgia Action UK, UK Fibromyalgia, ENFA, Fibromyalgia Australia, National ME/FM Action Network), then expanded by region (Ireland, New Zealand, South Africa, India, Germany, Sweden, Norway, Netherlands) via web search and via ENFA's own member roster. Each organization's own site (or an authoritative page about it: charity regulator/evaluator profile, national health portal, umbrella-network roster) was fetched directly; organizations that could not be fetched are listed separately as unverified rather than silently included.
  3. Patient stories and news features. Organization story content (NFA "Not Forgotten" patient videos; FMA UK newsletter stories) was noted from fetched org pages and summarized in aggregate only. News/feature items about public figures (Lady Gaga, Kirsty Young) were fetched individually; public figures may be named per the ethics rules.
  4. Video. YouTube content was identified via web search (site:youtube.com + fibromyalgia my story / living with fibromyalgia / hospital patient story / awareness day). Videos are cited from the search listings actually seen (title, channel where shown, URL); videos were not played and transcripts were not retrieved — see the coverage-limits note in sources.md.

Ethics rules applied (from CONVENTIONS.md §3)

  1. Public sources only. Nothing from closed groups, private forums, or any logged-in context. Several organizations run private Facebook/WhatsApp groups (UK Fibromyalgia's 28,000-member private group; Arthritis NZ's Facebook group): their existence is noted, their contents were never accessed. Published studies that themselves analyzed public social-media content (e.g., Millar 2024, PMID 38333024, on Facebook peer-support posts) are cited as studies; we did not access the underlying communities.
  2. Paraphrase, don't harvest. Patient experiences are paraphrased; direct quotes are ≤15 words and attributed to the publishing source.
  3. No names or identifying details of private individuals. Story pages and videos are summarized in aggregate ("multiple patients describe…"). Where a publisher's own page or video title contains a private individual's name, the name is omitted or elided in our citation; the URL preserves verifiability. Public figures and organization spokespeople (Lady Gaga, Kirsty Young, Florence Nightingale, NFA founder Lynne Matallana, advocate Thomas Hennessy Jr., National ME/FM Action Network founder Lydia Neilson) may be named.
  4. No cross-source dossiers. No individual's story is compiled across sources; each source is used only for the themes it itself reports.
  5. Aggregate reporting. Themes require ≥2 independent sources; single-story observations are not promoted to themes.

How to update this layer

  • Re-verify before extending. Any new organization gets a live fetch of its site (or an authoritative third-party page) before it enters organizations.md; record the access date. Dead links get marked, not deleted, until re-checked once more. Note that several FM org sites have TLS/hosting problems (see the quarantine table) — re-try them each sweep; two US organizations have also renamed or merged in the past decade, so check names against tax IDs.
  • New qualitative papers enter sources.md §(d) with PMIDs from a live PubMed query, and themes.md only if they add or strengthen a theme (≥2-source rule stands).
  • New story/video material: summarize in aggregate, apply the ethics rules above, and prefer hub pages over individual named stories for citation.
  • Propagate upward: changes here that alter conclusions must be reflected in wiki/patient-experience-and-advocacy.md, and the session logged in the condition LOG.md per repo protocol.
  • Periodic sweep cues: (a) the US organizational landscape is unstable (renames, dormancy) — check IRS/Charity Navigator status; (b) watch for the first FM-specific patient-partnered research infrastructure (a PCORI/NIHR-style collaborative analogous to what exists in aortic dissection) — none surfaced in this session's searches; (c) new drug approvals change the advocacy conversation (FMA UK's site was already tracking the FDA approval of Tonmya at this writing); (d) social-media-platform studies date quickly — TikTok/Instagram findings from 2018–2024 may not describe current platforms.